Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Johnson and Johnson
Accenture
US Army
Moodys
McKinsey
Cerilliant
US Department of Justice
Healthtrust

Generated: January 19, 2019

DrugPatentWatch Database Preview

Drug Price Trends for TADALAFIL

« Back to Dashboard

Drug Price Trends for TADALAFIL

Average Pharmacy Cost for TADALAFIL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
TADALAFIL 5 MG TABLET 66993-0701-38 8.25752 EA 2018-12-19
TADALAFIL 10 MG TABLET 66993-0702-30 43.28289 EA 2018-12-19
TADALAFIL 2.5 MG TABLET 00093-3016-30 7.90203 EA 2018-12-19
TADALAFIL 2.5 MG TABLET 00093-3016-65 7.90203 EA 2018-12-19
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for TADALAFIL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
CIALIS 5MG TAB Eli Lilly & Company 00002-4462-30 30 171.99 5.73300 EA 2018-08-01 - 2023-07-31 Big4
CIALIS 5MG TAB Eli Lilly & Company 00002-4462-30 30 224.98 2019-01-01 - 2023-07-31 Big4
CIALIS 5MG TAB Eli Lilly & Company 00002-4462-34 30 171.99 5.73300 EA 2018-08-01 - 2023-07-31 Big4
CIALIS 5MG TAB Eli Lilly & Company 00002-4462-34 30 225.77 2019-01-01 - 2023-07-31 Big4
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Citi
Cerilliant
Cipla
Medtronic
McKinsey
UBS
AstraZeneca
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.